Aurolife Pharma, LLC recalls
Every recall we track for Aurolife Pharma, LLC — 14 in all, from 2019–2023 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
Recalls from Aurolife Pharma, LLC peaked in 2019 (11); 14 since 2017.
All FDA recall records for Aurolife Pharma, LLC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 11 | 11 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 1 | 1 | 2 |
| 2023 | 0 | 0 | 0 | 1 | 1 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
Most common reasons for Aurolife Pharma, LLC recalls
What to do if you have a recalled Aurolife Pharma, LLC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Aurolife Pharma, LLC recalls
4 shown- UnratedDrug
Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East
Aurolife Pharma recalls 1 mg Glycopyrrolate tablets due to failed impurities tests. These prescription drugs may contain harmful substances. Consumers should contact the manufacturer for details.
AurolifeMay 18, 2023 - UnratedDrug
Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ
Aurolife Pharma recalls 1 mg Glycopyrrolate tablets (NDC 13107-014-01) due to failed impurities tests. These prescription drugs may have harmful levels of impurities that could affect safety.
AurolifeDec 16, 2022 - Lower riskDrug
Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279
Aurolife Pharma recalls 1 mg Glycopyrrolate tablets due to glass fragments in sealed bottles. This risk requires immediate action to avoid potential injury.
AurolifeMar 17, 2022 - UnratedDrug
Aurolife Pharma, LLC recalls Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011-0315-1); and b) 30-count
Aurolife Pharma recalls 180mg fexofenadine tablets with specific lot numbers due to failed impurities and degradation specifications. Consumers should check their packaging for NDC codes and lot numbers to determine if affected.
AurolifeAug 23, 2019
Aurolife Pharma, LLC recall questions
How many recalls has Aurolife Pharma, LLC had?
14 recalls from Aurolife Pharma, LLC are on record with U.S. safety agencies, from 2019–2023.
What is the most recent Aurolife Pharma, LLC recall?
Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East, dated May 18, 2023. Every Aurolife Pharma, LLC recall is listed on this page, newest first.
Why are Aurolife Pharma, LLC products recalled?
The most common reasons on record: Failed Impurities/Degradation Specifications (13).
What should I do if I have a recalled Aurolife Pharma, LLC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Aurolife Pharma, LLC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.